(Q41860282)

13 October 2017

Plasminogen in proliferative vitreoretinal disorders (English)

1 reference

13 October 2017

Esser P

1

1 reference

13 October 2017

Heimann K

2

1 reference

13 October 2017

Bartz-Schmidt KU

3

1 reference

13 October 2017

Walter P

4

1 reference

13 October 2017

Krott R

5

1 reference

13 October 2017

Weller M

6

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

British Journal of Ophthalmology

13 October 2017

1 reference

13 October 2017

81

1 reference

13 October 2017

7

1 reference

13 October 2017

590-594

1 reference

Protein measurement with the Folin phenol reagent

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Plasminogen: a brief introduction into its biochemistry and function

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Basics and practice in evaluating plasminogen

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Plasminogen activation: biochemistry, physiology, and therapeutics

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Blood coagulation factor XIII contributes to the development of traction retinal detachment

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Biochemical and biological aspects of the plasminogen activation system

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Clinical use of recombinant plasminogen activator for intraocular fibrinolysis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Thrombospondin: a new attachment protein in preretinal traction membranes

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation)

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Methods for Determination of Plasmin, Antiplasmin and Plasminogen by Means of Substrate S-2251

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1722258

Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy

5 June 2018

1 reference

12 December 2020

Increased thromboplastic potential in diabetes: a multifactorial phenomenon

1 reference

12 December 2020

Treatment of experimental intravitreal fibrin with tissue plasminogen activator

1 reference

12 December 2020

The significance of fibronectin in vitreoretinal pathology. A critical evaluation

1 reference

12 December 2020

Plasmin in subretinal fluid

1 reference

12 December 2020

Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage

1 reference

12 December 2020

Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator

1 reference

12 December 2020

Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1

1 reference

12 December 2020

Extracellular release of tissue plasminogen activator is increased with the phagocytic activity of the retinal pigment epithelium

1 reference

12 December 2020

Tissue plasminogen activator for postvitrectomy fibrin formation

1 reference

12 December 2020

Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation

1 reference

12 December 2020

Giant preretinal membrane formation behind a silicone oil bubble in a hypotensive eye

1 reference

12 December 2020

Complications of tissue plasminogen activator therapy after vitrectomy for diabetes

1 reference

12 December 2020

Tissue Plasminogen Activator Treatment of Experimental Subretinal Hemorrhage

1 reference

12 December 2020

Immunolocalization of tissue plasminogen activator in the diabetic and nondiabetic retina and choroid

1 reference

12 December 2020

Fibrin directs early retinal damage after experimental subretinal hemorrhage

1 reference

12 December 2020

Tissue plasminogen activator treatment of experimental subretinal hemorrhage

1 reference

12 December 2020

Tissue plasminogen activating factor assisted removal of subretinal hemorrhage

1 reference

12 December 2020

Tissue plasminogen activator irrigation to facilitate removal of subretinal hemorrhage during vitrectomy

1 reference

12 December 2020

Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1

1 reference

12 December 2020

Pharmacologic induction of posterior vitreous detachment in the rabbit

1 reference

12 December 2020

The use of tissue plasminogen activator in postvitrectomy cases

1 reference

12 December 2020

The significance of vitronectin in proliferative diabetic retinopathy

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.81.7.590

1 reference

13 October 2017

1 reference

13 October 2017

1 reference